We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Current and Emerging Therapies for Chronic Spontaneous Urticaria: A Narrative Review.
- Authors
Yosipovitch, Gil; Biazus Soares, Georgia; Mahmoud, Omar
- Abstract
Chronic spontaneous urticaria (CSU) is a condition in which wheals, angioedema, and pruritus occur spontaneously and recurrently for at least 6 weeks. The etiology of this disease is partially dependent on production of autoantibodies that activate and recruit inflammatory cells. Although the wheals can resolve within 24 h, symptoms have a significant detrimental impact on the quality of life of these patients. Standard therapy for CSU includes second-generation antihistamines and omalizumab. However, many patients tend to be refractory to these therapies. Available treatments such as cyclosporine, dapsone, dupilumab, and tumor necrosis factor alpha (TNFa) inhibitors have been used with success in some cases. Furthermore, various biologics and other novel drugs have emerged as potential treatments for this condition, and many more are currently under investigation in randomized clinical trials.
- Subjects
URTICARIA; TUMOR necrosis factors; ETIOLOGY of diseases; CLINICAL trials; DUPILUMAB; OMALIZUMAB
- Publication
Dermatology & Therapy, 2023, Vol 13, Issue 8, p1647
- ISSN
2193-8210
- Publication type
Article
- DOI
10.1007/s13555-023-00972-6